Showing results (1421-1430 of 6,404) with videos related to

Sort By:
Pageof 641
World Journal of Urology|February 22, 2024
Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinomaAngelika Borkowetz, Ulrich Sommer, Gustavo Baretton, et al.
World Journal of Urology|February 19, 2024
Modified Y-V plasty based on MRU evaluation for iatrogenic bladder outlet obliteration: a multicentre experience in ChinaKun Zheng, Yinglong Sa, Chuan Hao, et al.
World Journal of Urology|February 19, 2024
The association between patient and disease characteristics, and the risk of disease progression in patients with prostate cancer on active surveillanceMatthijs Duijn, Theo M de Reijke, Kurdo Barwari, et al.
World Journal of Urology|February 22, 2024
Malignant ureteral obstruction: comparison of metallic, 8 French and 6 French ureteric stents after failure of initial ureteric stentKatherine Ong, James Chen, Jennifer Kong, et al.
World Journal of Urology|February 3, 2024
Neurological sphincter deficiency: is there a place for artificial urinary sphincter?Desiree Vrijens, Harry Kendall, François Hervé
World Journal of Urology|May 24, 2024
The impact of low pressure pneumoperitoneum in robotic assisted radical prostatectomy II: a prospective, randomized, double blinded trialKevin Keating, Charla Holdren, Richard Eames, et al.
World Journal of Urology|May 22, 2024
A machine learning approach using stone volume to predict stone-free status at ureteroscopyGanesh Vigneswaran, Ren Teh, Francesco Ripa, et al.
World Journal of Urology|May 17, 2024
Fluid absorption during flexible ureteroscopy with intelligent control of renal pelvic pressure: a randomized controlled trialXiaolin Deng, Yijian Chen, Qiliang Zhai, et al.
World Journal of Urology|May 17, 2024
Do alpha blockers reduce the risk of urinary retention post-transperineal prostate biopsy? A systematic narrative reviewZein Alhamdani, Samuel Poppenbeek, Damien Bolton, et al.
World Journal of Urology|May 11, 2024
Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocolsReuben Ben-David, Neeraja Tillu, Parissa Alerasool, et al.
Pageof 641